Company · CIK 0001616212
Trillium Therapeutics Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
British Columbia, Canada
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/ATrillium Therapeutics Inc.0001072613-21-000655 · 104.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-21-140375 · 246.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-21-140044 · 201.7 KBSEC(opens sec.gov)
- SC 13G/ATrillium Therapeutics Inc.0001104659-21-139247 · 58.5 KBSEC(opens sec.gov)
- 10-QQuarterly update0001558370-21-015625 · 5.8 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-21-131337 · 219.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-21-130208 · 230.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-21-127796 · 225.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-21-126368 · 210.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-21-125669 · 210.4 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
2488 DUNWIN DRIVE
MISSISSAUGA, A6, L5L 1J9
mailing
2488 DUNWIN DRIVE
MISSISSAUGA, A6, L5L 1J9
Same industry